chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, Post-acute COVID-19 syndrome, Respiratory failure
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10043071;TACHYCARDIA; Narrative: Patient has received two Pfizer COVID 19 vaccines Feb 2022. The patient presented to the ED on 15 March 2023 with shortness of breath and tachycardia. The patient was diagnosed with COVID 19 on 4 March 2023 and was treated with molnupiravir. The patient was admitted to the hospital on 15 March 23 with respiratory failure and covid pneumonia. The patient was treated with remdesivir, oxygen, dexamethasone, and antibiotics. The patient was discharged on 16 March 2023 with long COVID on mycophenolate. Other Relevant HX: Other: Shortness of breath and tachycardia
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10043071;TACHYCARDIA; Narrative: Patient has received two Pfizer COVID 19 vaccines Feb 2022. The patient presented to the ED on 15 March 2023 with shortness of breath and tachycardia. The patient was diagnosed with COVID 19 on 4 March 2023 and was treated with molnupiravir. The patient was admitted to the hospital on 15 March 23 with respiratory failure and covid pneumonia. The patient was treated with remdesivir, oxygen, dexamethasone, and antibiotics. The patient was discharged on 16 March 2023 with long COVID on mycophenolate. Other Relevant HX: Other: Shortness of breath and tachycardia
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Cough, Fatigue, Fibrin D dimer increased
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10016581:FIBRIN D DIMER INCREASED; 10035664:PNEUMONIA; 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; 10047700:VOMITING; Narrative: Patient has received three Pfizer COVID 19 Vaccines Mar/Oct 21. The patient presented to the ED on 31 March 2023 with weakness, fatigue, nausea/vomiting, and fever. The patient was admitted with sepsis, covid pneumonia, and elevated D-dimer. The patient was treated with dexamethasone, remdesivir, and antibiotics. The patient was discharged in fair condition on 6 April 2023. Reported per EUA. Other Relevant HX: Other: SEPSIS, PNEUMONIA, ELEVATED D-DIMER
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Pneumonia, Pyrexia, Respiratory depression, Sepsis
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10016581:FIBRIN D DIMER INCREASED; 10035664:PNEUMONIA; 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; 10047700:VOMITING; Narrative: Patient has received three Pfizer COVID 19 Vaccines Mar/Oct 21. The patient presented to the ED on 31 March 2023 with weakness, fatigue, nausea/vomiting, and fever. The patient was admitted with sepsis, covid pneumonia, and elevated D-dimer. The patient was treated with dexamethasone, remdesivir, and antibiotics. The patient was discharged in fair condition on 6 April 2023. Reported per EUA. Other Relevant HX: Other: SEPSIS, PNEUMONIA, ELEVATED D-DIMER
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10016581:FIBRIN D DIMER INCREASED; 10035664:PNEUMONIA; 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; 10047700:VOMITING; Narrative: Patient has received three Pfizer COVID 19 Vaccines Mar/Oct 21. The patient presented to the ED on 31 March 2023 with weakness, fatigue, nausea/vomiting, and fever. The patient was admitted with sepsis, covid pneumonia, and elevated D-dimer. The patient was treated with dexamethasone, remdesivir, and antibiotics. The patient was discharged in fair condition on 6 April 2023. Reported per EUA. Other Relevant HX: Other: SEPSIS, PNEUMONIA, ELEVATED D-DIMER
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Brain natriuretic peptide increased, COVID-19, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; Narrative: 3/19/23 at 00:15 - Pt presented to ED with c/o shortness of breath, worse with exertion. Reported pt had orthopnea, dyspnea on exertion since yesterday. Pt negative for: fever, chills, pain, cough, hemoptysis, stridor, wheezing, urinary symptoms, GI issues, rash, home oxygen. On arrival to ER pt is alert & oriented; tachypneic; RR 24; O2sat 88%; only able to answer questions in one or two word sentences. Placed on 2L O2 NC. EKG and labs done. NO meds given in ED. Pt under observation 3/19/23 and it was decided to admit patient 3/20/23 with following diagnosis: Primary Diagnosis: Covid-19 illness; Secondary Diagnosis: CHF, chronic. Upon admission, diagnosis defined as: PRINCIPAL DIAGNOSIS (Reason for admission after study): symptomatic covid 19 infection ADDITIONAL DIAGNOSES: Shortness of breath related to covid, cardiac hx, bilateral PEs Heart failure reduced ejection fraction, not exacerbation diabetes type two hypomagnesemia GERD HOSPITAL COURSE: Admitted and treated for symptomatic COVID Infection (Pt has had three vaccinations). Was afebrile, but weak and SOB w cough, was placed on remdesivir IV x 3 days, (not given steroids) and weaned from O2 w sats 99% on RA at time of DC, cautioned to stay home and isolate for next 10-14 days wear mask avoid crowds. He remained SOB at dc, likely r/t covid and recent Hx bilat PEs, doubt CHF decompensation at this time his BNP is chronically elevated but stable and admission chest x-ray = no pulmonary edema but + trace pleural effusion which had
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea exertional, Electrocardiogram, Laboratory test, Orthopnoea
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; Narrative: 3/19/23 at 00:15 - Pt presented to ED with c/o shortness of breath, worse with exertion. Reported pt had orthopnea, dyspnea on exertion since yesterday. Pt negative for: fever, chills, pain, cough, hemoptysis, stridor, wheezing, urinary symptoms, GI issues, rash, home oxygen. On arrival to ER pt is alert & oriented; tachypneic; RR 24; O2sat 88%; only able to answer questions in one or two word sentences. Placed on 2L O2 NC. EKG and labs done. NO meds given in ED. Pt under observation 3/19/23 and it was decided to admit patient 3/20/23 with following diagnosis: Primary Diagnosis: Covid-19 illness; Secondary Diagnosis: CHF, chronic. Upon admission, diagnosis defined as: PRINCIPAL DIAGNOSIS (Reason for admission after study): symptomatic covid 19 infection ADDITIONAL DIAGNOSES: Shortness of breath related to covid, cardiac hx, bilateral PEs Heart failure reduced ejection fraction, not exacerbation diabetes type two hypomagnesemia GERD HOSPITAL COURSE: Admitted and treated for symptomatic COVID Infection (Pt has had three vaccinations). Was afebrile, but weak and SOB w cough, was placed on remdesivir IV x 3 days, (not given steroids) and weaned from O2 w sats 99% on RA at time of DC, cautioned to stay home and isolate for next 10-14 days wear mask avoid crowds. He remained SOB at dc, likely r/t covid and recent Hx bilat PEs, doubt CHF decompensation at this time his BNP is chronically elevated but stable and admission chest x-ray = no pulmonary edema but + trace pleural effusion which had
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pleural effusion, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; Narrative: 3/19/23 at 00:15 - Pt presented to ED with c/o shortness of breath, worse with exertion. Reported pt had orthopnea, dyspnea on exertion since yesterday. Pt negative for: fever, chills, pain, cough, hemoptysis, stridor, wheezing, urinary symptoms, GI issues, rash, home oxygen. On arrival to ER pt is alert & oriented; tachypneic; RR 24; O2sat 88%; only able to answer questions in one or two word sentences. Placed on 2L O2 NC. EKG and labs done. NO meds given in ED. Pt under observation 3/19/23 and it was decided to admit patient 3/20/23 with following diagnosis: Primary Diagnosis: Covid-19 illness; Secondary Diagnosis: CHF, chronic. Upon admission, diagnosis defined as: PRINCIPAL DIAGNOSIS (Reason for admission after study): symptomatic covid 19 infection ADDITIONAL DIAGNOSES: Shortness of breath related to covid, cardiac hx, bilateral PEs Heart failure reduced ejection fraction, not exacerbation diabetes type two hypomagnesemia GERD HOSPITAL COURSE: Admitted and treated for symptomatic COVID Infection (Pt has had three vaccinations). Was afebrile, but weak and SOB w cough, was placed on remdesivir IV x 3 days, (not given steroids) and weaned from O2 w sats 99% on RA at time of DC, cautioned to stay home and isolate for next 10-14 days wear mask avoid crowds. He remained SOB at dc, likely r/t covid and recent Hx bilat PEs, doubt CHF decompensation at this time his BNP is chronically elevated but stable and admission chest x-ray = no pulmonary edema but + trace pleural effusion which had
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Anosmia, COVID-19, Chest pain, Confusional state
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cough, Diarrhoea, Fibrin D dimer increased, Headache, Myalgia
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chills, Cough, Headache
Clinical narrative: Reported Symptoms: 10011232:COUGHING: 10016558:FEVER: 10019211:HEADACHE; 10047700:VOMITING; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the Emergency Department on 4 Jan 2023 with chills, fever, chough, headache, and nausea that he had for approximately one week. The patient tested positive for COVID 19 on 4 Jan 2023 and was admitted to the hospital with COVID pneumonia and abnormal LFTs (mild hepatitis). The patient was treated with remdesivir, dexamethasone, and inhalation therapy. The patient was discharged on 7 Jan 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pneumonia
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hepatitis, Liver function test abnormal, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10011232:COUGHING: 10016558:FEVER: 10019211:HEADACHE; 10047700:VOMITING; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the Emergency Department on 4 Jan 2023 with chills, fever, chough, headache, and nausea that he had for approximately one week. The patient tested positive for COVID 19 on 4 Jan 2023 and was admitted to the hospital with COVID pneumonia and abnormal LFTs (mild hepatitis). The patient was treated with remdesivir, dexamethasone, and inhalation therapy. The patient was discharged on 7 Jan 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pneumonia
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Reported Symptoms: 10011232:COUGHING: 10016558:FEVER: 10019211:HEADACHE; 10047700:VOMITING; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the Emergency Department on 4 Jan 2023 with chills, fever, chough, headache, and nausea that he had for approximately one week. The patient tested positive for COVID 19 on 4 Jan 2023 and was admitted to the hospital with COVID pneumonia and abnormal LFTs (mild hepatitis). The patient was treated with remdesivir, dexamethasone, and inhalation therapy. The patient was discharged on 7 Jan 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pneumonia
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Reported Symptoms: 10037087:PRURITUS; Narrative: Other Relevant HX:
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome, Refusal of vaccination
Clinical narrative: Reported Symptoms:  10018767:GUILLAN-BARRE SYNDROME;    Narrative:  Other Relevant HX: Per chart review, on 4/24/23 (same day ADR was listed) Patient had PCP visit and he refused the receive the influenza vaccine. No order was placed for a vaccine, nor was a vaccine administered in clinic per chart review. ADR entered as "historical" indicating event did not occur at that visit.  Other: GUILLAIN BARRE
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10037087:PRURITUS; 10046735:URTICARIA; Narrative: Recurrence of urticarial rash following 2nd Shingrix dose. Treated with famotidine and cetirizine with resolution. Other Relevant HX: Other: URTICARIA
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Immunisation reaction, Rash
Clinical narrative: Reported Symptoms: 10037044:RASH; 10046860:VACCINATION ADVERSE REACTION; 10081826:HERPES ZOSTER IMMUNIZATION; Narrative: Other Relevant HX: Other: Due to Herpes Zoster (recombinant) vaccine
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Leg amputation, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male with PMH for bilateral PAD s/p L SFA, L pop, L EIA, and L CIA stenting and angioplasty in 2016 w known R SFA occlusion, asymptomatic carotid stenosis, a fib on Eliquis, tobacco use disorder, immobility and hx of recent GI and GU surgeries. The patient was initially admitted to the Vascular surgery service with Medicine and ID in consultation. Pt required a L AKA on 11/23/22. Pt was transferred to hospitalist service on 11/30/22 as there were no acute vascular issues and the patient was found to be COVID positive. Pt received remdesivir (11/29-12/1). Pt was minimally symptomatic and did not require supplemental oxygen. Pt also treated for UTI. Pt discharged to NH on 12/02/2022. Other Relevant HX: 72 yo male with PMH for bilateral PAD s/p L SFA, L pop, L EIA and L CIA stenting and angioplasty in 2016 w known R SFA occlusion, asymptomatic carotid stenosis, a fib on Eliquis, tobacco use disorder, immobility and hx of recent GI and GU surgeries. Other: Covid Infection prolonged hospital stay
Age: 70.0
Sex: M
Vaccine: TDAP
Symptoms: Delirium, Pain, Pain in extremity
Clinical narrative: Reported Symptoms: 10000424:ACHE; 10012218:DELIRIUM; Narrative: 4/11/23 - Pt reports the vaccine he received for tetanus on 4/4/23 is still been bothering him and he has a sore arm. He reports the pain is better but still hurting him pretty good. Provider flagged Pt's chart with adverse event to vaccines = generalized aches and delirium, but no progress note reflecting delirium. Other Relevant HX: Other: GENERALIZED ACHES AND PAIN; DELIRIUM
Age: 83.0
Sex: M
Vaccine: FLU4
Symptoms: Agitation, Cerebrovascular accident, Confusional state, Vomiting
Clinical narrative: Reported Symptoms: 10001497:AGITATION; 10010300:CONFUSION; 10042244:STROKE; 10047700:VOMITING; Narrative: Other Relevant HX: Other:
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills, Cough
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1 presented to ED on 12/02/2022 w/ several days of aches, fever, mild sob, cough and chills. Patient tested positive for COVID-19 at pharmacy. Pt indicated he was advised to go to ED for 3 days of remdesivir after contacting nephrology and transplant team. Pt received initial dose of remdesivir and temperature increased to 103.4 with shaking and chills. Admission to hospital was requested at that time and remdesivir discontinued. 12/03/22 chest x-ray indicated infiltrates. Pt w/ COVID PNA. Pt weaned off supplemental O2. Pt improved and discharged to home on 12/04/2022. Other Relevant HX: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1. Other: Covid infection w/ hospitalization
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Lung infiltration, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1 presented to ED on 12/02/2022 w/ several days of aches, fever, mild sob, cough and chills. Patient tested positive for COVID-19 at pharmacy. Pt indicated he was advised to go to ED for 3 days of remdesivir after contacting nephrology and transplant team. Pt received initial dose of remdesivir and temperature increased to 103.4 with shaking and chills. Admission to hospital was requested at that time and remdesivir discontinued. 12/03/22 chest x-ray indicated infiltrates. Pt w/ COVID PNA. Pt weaned off supplemental O2. Pt improved and discharged to home on 12/04/2022. Other Relevant HX: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1. Other: Covid infection w/ hospitalization
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tremor
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1 presented to ED on 12/02/2022 w/ several days of aches, fever, mild sob, cough and chills. Patient tested positive for COVID-19 at pharmacy. Pt indicated he was advised to go to ED for 3 days of remdesivir after contacting nephrology and transplant team. Pt received initial dose of remdesivir and temperature increased to 103.4 with shaking and chills. Admission to hospital was requested at that time and remdesivir discontinued. 12/03/22 chest x-ray indicated infiltrates. Pt w/ COVID PNA. Pt weaned off supplemental O2. Pt improved and discharged to home on 12/04/2022. Other Relevant HX: 39 yo male patient with PMH significant for renal disease status post renal pancreatic transplant 2016, rejection, CKD, CMV complication, and diabetes mellitus type 1. Other: Covid infection w/ hospitalization
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE;   Narrattive: Hospitalization-COVIS positive, fully vaccinated - symptomatic. Treated with dexamethasone, ceftriaxone, and doxycycline.  Other Relevant Hx: Other: Hospitalization-COVID positive, fully vaccinated - symptomatic
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Contraindication to vaccination
Clinical narrative: Reported Symptoms: 10002855:ANXIETY; Narrative: Other Relevant HX: Patient presented for PCP visit on 4/11/23. During this visit, LPN documented patient had contraindication for Pfizer COVID-19 vaccine. Reaction was recorded as "historical" and per chart review COVID 19 vaccine was never ordered/administrated at facility. Other: ANXIETY
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE;   Narrative: Hospitalization- incidental COVID positive test for disposition to facility, fully vaccinated Other Relevant Hx:  Other: Hospitalization- incidental COVID positive, fully vaccinated
Age: 78.0
Sex: M
Vaccine: FLUX
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Reported Symptoms: 10037087:PRURITUS;  10037844:RASH;  10046735:URTICARIA; Narrative:  Other Relevant HX:  Other: PRURITUS; URTICARIA; RASH
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Dizziness
Clinical narrative: Reported Symptoms: 10002855:ANXIETY; 10013573:DIZZINESS; Narrative: Per nursing note 4/3/2023, historical reporting she identified it as a severe reaction. I do not have enough information to finish the questions. Other Relevant HX: Other: DIZZINESS; ANXIETY
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization-COVID positive, fully vaccinated. Admitted for CAP and COVID positive Other Relevant HX: Other: Hospitalization-COVID positive, fully vaccinated
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization-COVID positive, fully vaccinated. Admitted with symptomatic COVID and NSTEMI type II. Other Relevant HX: Other: Hospitalization-COVID positive, fully vaccinated
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19-2, COVID19-2
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Fibrin D dimer increased, Influenza like illness
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10016581:FIBRIN D DIMER INCREASED; 10033556:PALPITATION; 10035664:PNEUMONIA; 10043088:TACHYPNEA; 10084268:COVID-19; Narrative: The patient received three doses of Moderna COVID 19 Vaccine Feb/Mar/Dec 2021. The patient presented to the ED on 7 May 2023 with flulike symptoms (fever and cough) and palpitations. The patient tested positive for COVID 19 on 7 May 2023 and was admitted with COVID pneumonia and positive D-dimer. The patient was treated with remdesivir, dexamethasone, and enoxaparin. The patient was discharged on 12 May 2023 in stable condition on anticoagulant due to positive D-dimer. Reported per EUA. Other Relevant HX: Other: positive D-Dimer, COVID pneumonia
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19-2, COVID19-2
Symptoms: Palpitations, Pneumonia, Pyrexia, SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10016581:FIBRIN D DIMER INCREASED; 10033556:PALPITATION; 10035664:PNEUMONIA; 10043088:TACHYPNEA; 10084268:COVID-19; Narrative: The patient received three doses of Moderna COVID 19 Vaccine Feb/Mar/Dec 2021. The patient presented to the ED on 7 May 2023 with flulike symptoms (fever and cough) and palpitations. The patient tested positive for COVID 19 on 7 May 2023 and was admitted with COVID pneumonia and positive D-dimer. The patient was treated with remdesivir, dexamethasone, and enoxaparin. The patient was discharged on 12 May 2023 in stable condition on anticoagulant due to positive D-dimer. Reported per EUA. Other Relevant HX: Other: positive D-Dimer, COVID pneumonia
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Syncope, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization-COVID positive, fully vaccinated. Admitted for syncope. Given remdesivir and dexamethasone Other Relevant HX: Other: Hospitalization-COVID positive, fully vaccinated
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Angioedema, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Reported Symptoms: 10002424:ANGIOEDEMA; 10010953:COPD EXACERBATION; 10011232:COUGHING; 10046735:URTICARIA; 10054112:HOSPITALISATION; Narrative: Patient was a 62-year-old male with PMH significant for schizophrenia, EtOH and substance use disorder, active smoker, HTN, emphysema, and chronic cough (>5 months), who got admitted to facility for housing track. On 1/9/23, patient received the second shot of shingles vaccine at facility around 9AM, then he developed lip swelling and worsening cough when getting back to facility. He was given prednisone 50 mg po x1, diphenhydramine 25 mg po x1, and albuterol 3mg/ipratropium 0.5 mg with no improvement. VS (1/9/23 @1250): Temp 97.8; HR 102; RR 20; BP 132/78; SpO2 97%. Around 06:16 PM, EMS was called; he was given epinephrine 0.3 mg, diphenhydramine 50 mg po; then he was taken to ER. VS (1/9/23 @1053: Temp 98.3; BP 149/91; HR 107; RR 18; SpO2 97%). In ER, he received 2 additional doses of epinephrine, famotidine, and ondansetron, and was discharged back to facility. He was diagnosed with angioedema reaction and COPD exacerbation secondary to reaction with shingles vaccine. At facility, he was started on prednisone taper for COPD exacerbation. He was also on lisinopril 10 mg daily (started 12/27/22), which was discontinued, and amlodipine 2.5 mg daily was started for HTN management. Starting 1/11/23, patient reported his lip swelling and breathing had been better. Per 1/17/23 Medicine Inpt note, patient's lips feel back to normal; and starting 1/23/23, he was back to 90% of baseline. Patient continued on prednisone taper and was.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Hypertension, Immunisation reaction, Lip swelling, Urticaria
Clinical narrative: Reported Symptoms: 10002424:ANGIOEDEMA; 10010953:COPD EXACERBATION; 10011232:COUGHING; 10046735:URTICARIA; 10054112:HOSPITALISATION; Narrative: Patient was a 62-year-old male with PMH significant for schizophrenia, EtOH and substance use disorder, active smoker, HTN, emphysema, and chronic cough (>5 months), who got admitted to facility for housing track. On 1/9/23, patient received the second shot of shingles vaccine at facility around 9AM, then he developed lip swelling and worsening cough when getting back to facility. He was given prednisone 50 mg po x1, diphenhydramine 25 mg po x1, and albuterol 3mg/ipratropium 0.5 mg with no improvement. VS (1/9/23 @1250): Temp 97.8; HR 102; RR 20; BP 132/78; SpO2 97%. Around 06:16 PM, EMS was called; he was given epinephrine 0.3 mg, diphenhydramine 50 mg po; then he was taken to ER. VS (1/9/23 @1053: Temp 98.3; BP 149/91; HR 107; RR 18; SpO2 97%). In ER, he received 2 additional doses of epinephrine, famotidine, and ondansetron, and was discharged back to facility. He was diagnosed with angioedema reaction and COPD exacerbation secondary to reaction with shingles vaccine. At facility, he was started on prednisone taper for COPD exacerbation. He was also on lisinopril 10 mg daily (started 12/27/22), which was discontinued, and amlodipine 2.5 mg daily was started for HTN management. Starting 1/11/23, patient reported his lip swelling and breathing had been better. Per 1/17/23 Medicine Inpt note, patient's lips feel back to normal; and starting 1/23/23, he was back to 90% of baseline. Patient continued on prednisone taper and was.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atelectasis, Atrial fibrillation, COVID-19
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for bipolar disorder, CKD stage III, hypertension, T2DM, and obesity who transferred to hospital on 10/19/22 from another hospital for treatment of acute hypoxic respiratory failure secondary to COVID-19 infection as other hospital had no COVID beds available. Pt with COVID PNA and received supplemental 02, supportive medications, remdesivir (10/19-10/21)and dexamethasone (10/19-10/27). COVID PNA resolved 10/28/2022. Patient was deemed medically stable, off COVID precaution, and about to be transferred to a SNF. Pt upgraded to ICU on 11/01/22 when pt mentation and 02 needs steadily increased needing 45L 70% O2 on HFNC. Suspected aspiration pneumonia given location of infiltrate and worsening hypoxia that occurred following a change in mentation. Pt received cefepime (11/2-11/8) and oseltamivir (11/3-11/7). CTA was repeated on 11/9 due to persistent hypoxemia and shunt physiology requiring high flow nasal cannula and showed right lower lobe atelectasis. Thought to be likely the etiology of his shunt physiology (intrapulmonary shunt around atelectatic region) and required aggressive physical therapy with PEEP therapy to aerate and open up the collapse/atelectatoc alveoli, Chest xray on 11/13 showed some improvement in aeration on right side. He maintained 6L midflow which was a dramatic improvement. Downgraded from ICU to floor on 11/15. Pt in atrial fibrillation with RVR on 11/16/22. Pt w/ severe deconditioning during hospital stay. Pt had a duotube placed early in his stay.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Duodenostomy, Hypoxia, Intensive care
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for bipolar disorder, CKD stage III, hypertension, T2DM, and obesity who transferred to hospital on 10/19/22 from another hospital for treatment of acute hypoxic respiratory failure secondary to COVID-19 infection as other hospital had no COVID beds available. Pt with COVID PNA and received supplemental 02, supportive medications, remdesivir (10/19-10/21)and dexamethasone (10/19-10/27). COVID PNA resolved 10/28/2022. Patient was deemed medically stable, off COVID precaution, and about to be transferred to a SNF. Pt upgraded to ICU on 11/01/22 when pt mentation and 02 needs steadily increased needing 45L 70% O2 on HFNC. Suspected aspiration pneumonia given location of infiltrate and worsening hypoxia that occurred following a change in mentation. Pt received cefepime (11/2-11/8) and oseltamivir (11/3-11/7). CTA was repeated on 11/9 due to persistent hypoxemia and shunt physiology requiring high flow nasal cannula and showed right lower lobe atelectasis. Thought to be likely the etiology of his shunt physiology (intrapulmonary shunt around atelectatic region) and required aggressive physical therapy with PEEP therapy to aerate and open up the collapse/atelectatoc alveoli, Chest xray on 11/13 showed some improvement in aeration on right side. He maintained 6L midflow which was a dramatic improvement. Downgraded from ICU to floor on 11/15. Pt in atrial fibrillation with RVR on 11/16/22. Pt w/ severe deconditioning during hospital stay. Pt had a duotube placed early in his stay.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Lung disorder, Lung infiltration, Mental status changes, Physical deconditioning, Pneumonia aspiration
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for bipolar disorder, CKD stage III, hypertension, T2DM, and obesity who transferred to hospital on 10/19/22 from another hospital for treatment of acute hypoxic respiratory failure secondary to COVID-19 infection as other hospital had no COVID beds available. Pt with COVID PNA and received supplemental 02, supportive medications, remdesivir (10/19-10/21)and dexamethasone (10/19-10/27). COVID PNA resolved 10/28/2022. Patient was deemed medically stable, off COVID precaution, and about to be transferred to a SNF. Pt upgraded to ICU on 11/01/22 when pt mentation and 02 needs steadily increased needing 45L 70% O2 on HFNC. Suspected aspiration pneumonia given location of infiltrate and worsening hypoxia that occurred following a change in mentation. Pt received cefepime (11/2-11/8) and oseltamivir (11/3-11/7). CTA was repeated on 11/9 due to persistent hypoxemia and shunt physiology requiring high flow nasal cannula and showed right lower lobe atelectasis. Thought to be likely the etiology of his shunt physiology (intrapulmonary shunt around atelectatic region) and required aggressive physical therapy with PEEP therapy to aerate and open up the collapse/atelectatoc alveoli, Chest xray on 11/13 showed some improvement in aeration on right side. He maintained 6L midflow which was a dramatic improvement. Downgraded from ICU to floor on 11/15. Pt in atrial fibrillation with RVR on 11/16/22. Pt w/ severe deconditioning during hospital stay. Pt had a duotube placed early in his stay.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Positive end-expiratory pressure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for bipolar disorder, CKD stage III, hypertension, T2DM, and obesity who transferred to hospital on 10/19/22 from another hospital for treatment of acute hypoxic respiratory failure secondary to COVID-19 infection as other hospital had no COVID beds available. Pt with COVID PNA and received supplemental 02, supportive medications, remdesivir (10/19-10/21)and dexamethasone (10/19-10/27). COVID PNA resolved 10/28/2022. Patient was deemed medically stable, off COVID precaution, and about to be transferred to a SNF. Pt upgraded to ICU on 11/01/22 when pt mentation and 02 needs steadily increased needing 45L 70% O2 on HFNC. Suspected aspiration pneumonia given location of infiltrate and worsening hypoxia that occurred following a change in mentation. Pt received cefepime (11/2-11/8) and oseltamivir (11/3-11/7). CTA was repeated on 11/9 due to persistent hypoxemia and shunt physiology requiring high flow nasal cannula and showed right lower lobe atelectasis. Thought to be likely the etiology of his shunt physiology (intrapulmonary shunt around atelectatic region) and required aggressive physical therapy with PEEP therapy to aerate and open up the collapse/atelectatoc alveoli, Chest xray on 11/13 showed some improvement in aeration on right side. He maintained 6L midflow which was a dramatic improvement. Downgraded from ICU to floor on 11/15. Pt in atrial fibrillation with RVR on 11/16/22. Pt w/ severe deconditioning during hospital stay. Pt had a duotube placed early in his stay.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: hospitalization- incidental COVID positive during admission upon testing for LTAC placement Other Relevant HX: Other: hospitalization- incidental COVID positive during admission upon testing for placement
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Fully vaccinated, COVID positive 3 days prior to admit. Admitted for COVID pneumonia and treated with dexamethasone then prednisone for COPD exacerbation. Also received azithromycin and ceftriaxone. Discharged home on levofloxacin, prednisone, and resumed home chronic azithromycin. Other relevant HX: Other: Hospitalization-COVID positive, fully vaccinated
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Fully vaccinated, COVID positive 3 days prior to admit. Admitted for COVID pneumonia and treated with dexamethasone then prednisone for COPD exacerbation. Also received azithromycin and ceftriaxone. Discharged home on levofloxacin, prednisone, and resumed home chronic azithromycin. Other relevant HX: Other: Hospitalization-COVID positive, fully vaccinated
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Anion gap, Asthma, Basophil percentage increased, Blood calcium normal, Blood chloride increased
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea normal
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Carbon dioxide normal, Condition aggravated, Eosinophil count normal, Eosinophil percentage increased
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Glomerular filtration rate normal, Granulocyte count, Granulocyte percentage, Haematocrit decreased
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin normal, Laboratory test, Lymphocyte count normal, Lymphocyte percentage, Mean cell haemoglobin concentration normal
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell haemoglobin increased, Mean cell volume increased, Mean platelet volume normal, Monocyte count normal, Monocyte percentage
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler